Crohn's Disease and Colitis Trial, Recruiting (NCT05895981)

Crohn's Disease and Colitis Trial, Recruiting NCT05895981 Sponsor: Xijing Hospital Condition: Crohn's Disease and Colitis

Printed from Voxsanity (voxsanity.com.au) — NCT05895981 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Crohns Disease And Colitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You must be 18 years of age or older
You must have been diagnosed with ulcerative colitis for at least 3 months
Your ulcerative colitis must be rated as moderate to severe based on specific scoring systems used by doctors (confirm with trial site)
Your ulcerative colitis must not have responded well to previous medical treatments

Who may not be able to join:

You have never received any treatment for your ulcerative colitis before
You are currently experiencing a severe, sudden flare-up of ulcerative colitis
You are currently taking any biologic medications (a type of drug that targets the immune system)
You have previously had surgery related to your ulcerative colitis, or your condition is so severe that surgery may be needed very soon
Your colitis is caused by an infection
You have other serious conditions affecting your whole body (confirm with trial site)
You are currently pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kaichun Wu, PhD, Air Force Military Medical University, China

Phone: +8615529202305

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05895981

Sponsor: Xijing Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Crohn's Disease and Colitis

Trial contact: +8615529202305

More information: https://clinicaltrials.gov/study/NCT05895981

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You must be 18 years of age or older
You must have been diagnosed with ulcerative colitis for at least 3 months
Your ulcerative colitis must be rated as moderate to severe based on specific scoring systems used by doctors (confirm with trial site)
Your ulcerative colitis must not have responded well to previous medical treatments

Who may not be able to join:

You have never received any treatment for your ulcerative colitis before
You are currently experiencing a severe, sudden flare-up of ulcerative colitis
You are currently taking any biologic medications (a type of drug that targets the immune system)
You have previously had surgery related to your ulcerative colitis, or your condition is so severe that surgery may be needed very soon
Your colitis is caused by an infection
You have other serious conditions affecting your whole body (confirm with trial site)
You are currently pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Xijing Hospital

Registry

ClinicalTrials.gov

Start date

20 July 2023

Est. completion

1 March 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Change from baseline in the Mayo score at week 12

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov